Agency for Toxic Substances and Disease Registry

East Palestine, Ohio Group Launches Effort To Provide Air Purifiers To Homes Throughout The Train Derailment Disaster Area

Retrieved on: 
Wednesday, August 23, 2023
Poison, Rash, Atmosphere, Anxiety, Parent, Cancer, BGA, Agency for Toxic Substances and Disease Registry, Multimedia, Nosebleed, Hospital, Dioxin, Soil, First Church, Water, EAST, Health, FDA, First Church of Christ, Scientist, Brisbane, Rare-earth element, Pharmaceutical industry, Nursing

EAST PALESTINE, Ohio, Aug. 23, 2023 /PRNewswire-PRWeb/ -- A group called "HelpEastPalestineOhio.org" has created a fundraising campaign to provide medical-grade air purifiers to 2,500 homes and businesses in and around the disaster area where a train derailed on February 3, spilling more than a million pounds of hazardous chemicals that were ignited by authorities. For several days, a toxic plume blackened the skies of East Palestine and neighboring towns, contaminating the air, soil, and water, and continues to sicken many residents today.

Key Points: 
  • A group called HelpEastPalestineOhio.org aims to supply homes and small businesses within the affected area with free, medical grade air purifiers.
  • EAST PALESTINE, Ohio, Aug. 23, 2023 /PRNewswire-PRWeb/ -- A group called "HelpEastPalestineOhio.org" has created a fundraising campaign to provide medical-grade air purifiers to 2,500 homes and businesses in and around the disaster area where a train derailed on February 3, spilling more than a million pounds of hazardous chemicals that were ignited by authorities.
  • For several days, a toxic plume blackened the skies of East Palestine and neighboring towns, contaminating the air, soil, and water, and continues to sicken many residents today.
  • HelpEastPalestineOhio.org aims to supply homes and businesses within the affected area with free air purifiers.

Sorrento Announces the Full Enrollment of the Pivotal Phase 3 Trial with Olgotrelvir (OVYDSOTM) (STI-1558), a Second Generation Oral Mpro Inhibitor, as a Standalone Treatment for COVID-19

Retrieved on: 
Monday, June 26, 2023
Volunteering, Database, Microbiology, SARS-CoV-2, Safety, Efficacy, American Society for Microbiology, COVID-19, Dean, RNA, Professor, Patient, SAN, OTC, National Medical Products Administration, Agency for Toxic Substances and Disease Registry, Therapy, Society, NMPA, Pharmaceutical industry, Adult

During the trial, Ovydso has maintained an excellent safety profile with no Grade 3 toxicities reported.

Key Points: 
  • During the trial, Ovydso has maintained an excellent safety profile with no Grade 3 toxicities reported.
  • Should the Phase 3 trial be successful, we plan to open dialogue with regulatory agencies around the world to discuss paths to approval.
  • With the completion of enrollment for this trial, Sorrento has treated almost 1,450 volunteers and patients.
  • “We are pleased to see that Ovydso has enrolled quickly for a successful completion of enrollment for the phase 3 pivotal trial in China.

New Initiative: NC State Filling Demand for a Feline Health Center

Retrieved on: 
Tuesday, April 4, 2023
Cancer, Education, Internal medicine, Hospital, North Carolina State University, Veterinarian, Research, Cat, Thought, Patient, Behavioral Problems, Pet, Agency for Toxic Substances and Disease Registry, Health, Veterinary medicine, Behavioral medicine, Pharmaceutical industry, Nursing

Raleigh, NC, April 04, 2023 (GLOBE NEWSWIRE) -- RALEIGH, NC (April 4, 2023) — Noting a national need for more cat-focused care, the NC State College of Veterinary Medicine has created a Feline Health Center, consolidating all of its feline expertise under one umbrella.

Key Points: 
  • Raleigh, NC, April 04, 2023 (GLOBE NEWSWIRE) -- RALEIGH, NC (April 4, 2023) — Noting a national need for more cat-focused care, the NC State College of Veterinary Medicine has created a Feline Health Center, consolidating all of its feline expertise under one umbrella.
  • “With our Feline Health Center, we will put an intentional emphasis on improving cat health in multiple ways, including through research, enhanced educational opportunities for veterinarians and owners, innovative care for feline patients and community outreach,” says Dr. Kate Meurs, dean of the NC State College of Veterinary Medicine.
  • This center will be a good opportunity to share that.”
    The center has four missions: clinical service, research, community outreach and education.
  • Another focus will be making the NC State Veterinary Hospital, where some donors already have helped create cat-specific exam rooms, even more feline-friendly.

Burger Law Represents Plaintiffs in Camp Lejeune Water Contamination Suits

Retrieved on: 
Thursday, September 22, 2022
Blair Brandt, United States Court of Appeals for the Armed Forces, Drinking water, Water supply, Survivor, Navy, Federal district, Agency for Toxic Substances and Disease Registry, Birth, Volatile organic compound, Poison, Government, Camp, Agency, Cancer, Organic compound, Veteran, TCE, ABC, Trichloroethylene, Failure, Water, PCE, Appeal, Parkinson's disease, Lawyer, Death, Disease, Insurance, Fast food

JACKSONVILLE, N.C., Sept. 22, 2022 /PRNewswire/ -- The personal injury lawyers of Burger Law are now accepting clients who lived or worked on the U.S. Marine Corps Base Camp Lejeune in North Carolina between 1953 and 1987 for at least 30 days and experienced health problems. After President Joe Biden signed the PACT Act into law in Aug. of 2022, it is now possible for veterans and civilians to file lawsuits against the U.S. government and to collect benefits and additional compensation for illness, death and other damages suffered as a result of exposure to contaminated finished water on the base.

Key Points: 
  • Burger Law personal injury attorneys represent those seeking remedy after exposure to contaminated drinking water on the Camp Lejeune military base.
  • These and the other toxins present in the water at Camp Lejeune are linked to many serious illnesses including cancer, Parkinson's Disease and birth defects.
  • About Burger Law: Burger Law is a law firm based in St. Louis, MO and Chicago, IL, and represents clients throughout the United States.
  • Mr. Burger and the attorneys of Burger Law are currently accepting clients who wish to make a claim in the Camp Lejeune water contamination case as well as victims in other tort claims such as car accident injuries, wrongful death and product defect cases.

Physicians for Informed Consent (PIC) Releases New Educational Documents Assessing Risks of Hepatitis B Compared to Risks of the Hepatitis B Vaccine

Retrieved on: 
Tuesday, September 13, 2022
Institute, National Center for Health Statistics, Hepatitis, Safety, Center, Child, Seizure, Prevalence, Office of Inspector General, U.S. Department of Health and Human Services, Infant, Agency for Toxic Substances and Disease Registry, VRS, Vaccination, Hepatitis B, Immunity, Poison, U.S. Department of Commerce Office of Security, Agency, DIS, Aluminium, PIC, Human services, IOM, Physician, CDC, Korea Disease Control and Prevention Agency, Medical statistics, Parent, GLOBE, National Center for Immunization and Respiratory Diseases, Informed consent, Vaccine, Risk management

NEWPORT BEACH, Calif., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Physicians for Informed Consent ( PIC ) has released two new educational documents: Hepatitis B - Disease Information Statement (DIS) " Hepatitis B: What Parents Need to Know " and Hepatitis B - Vaccine Risk Statement (VRS) " Hepatitis B Vaccine: Is It Safer Than Hepatitis B? "

Key Points: 
  • NEWPORT BEACH, Calif., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Physicians for Informed Consent ( PIC ) has released two new educational documents: Hepatitis B - Disease Information Statement (DIS) " Hepatitis B: What Parents Need to Know " and Hepatitis B - Vaccine Risk Statement (VRS) " Hepatitis B Vaccine: Is It Safer Than Hepatitis B? "
  • Developed from data compiled by the Centers for Disease Control and Prevention (CDC) and the National Center for Health Statistics, the documents assist readers inassessing the risks of hepatitis B compared to the risks of the hepatitis B vaccine, so they can engage in making an informed vaccine decision.
  • Is the hepatitis B vaccine safer than hepatitis B?
  • The Physicians for Informed Consent documents demonstrate that the hepatitis B vaccine is not proven to be safer than hepatitis B for normal-risk children.

Actym Therapeutics Announces Significant Expansion of Senior Leadership

Retrieved on: 
Thursday, May 12, 2022
UC, Stanford University, Strategic planning, Chemical engineering, School, Dartmouth, UCSF, University, Business economics, Division, Cancer, Agency for Toxic Substances and Disease Registry, Tuck School of Business, Janssen Pharmaceuticals, Investment, Oregon State University, Therapy, Control, National Center for Manufacturing Sciences, Om, Johnson & Johnson, Hardpan, Board, University of California, Santa Barbara, Icahn School of Medicine at Mount Sinai, Business, SUGEN, Air force, Department, Company, Doctor of Philosophy, Director, IV, Strategy, FDA, Biotechnology, CBO, CA, Shantha Biotechnics, A-DNA, R, Economics, Patient, Business development, Sutro Biopharma, Pharmacology, M.B.A, MSAT, Bayer, United, Gilead Sciences, CEO, Pharmaceutical industry, Management, Vaxart, Technology, Symphogen

BERKELEY, Calif., May 12, 2022 /PRNewswire/ -- Actym Therapeutics,a privately held biotechnology company developing STACT, a novel therapeutic platform that delivers immunomodulatory payloads to solid tumors after IV dosing, announced today the significant expansion of its senior leadership team.

Key Points: 
  • BERKELEY, Calif., May 12, 2022 /PRNewswire/ -- Actym Therapeutics,a privately held biotechnology company developing STACT, a novel therapeutic platform that delivers immunomodulatory payloads to solid tumors after IV dosing, announced today the significant expansion of its senior leadership team.
  • "On behalf of the Executive Leadership Team and the Board of Directors, we are thrilled to welcome this accomplished group of leaders to Actym."
  • As Vice President, Technical Operations, Omkar will serve as a member of the Actym Executive Leadership Team and will be responsible for all aspects of technical development, manufacturing, analytical development, and quality at Actym.
  • Actym Therapeutics, based in Berkeley, CA, is a privately-held biotechnology company focused on discovery and development of novel immuno-oncology therapies to treat cancer.

EUREKA ERGONOMIC REPORTS THERE IS A SIMPLE WAY TO MAKE SURE YOUR ONLINE FURNITURE IS SAFE FROM FORMALDEHYDE

Retrieved on: 
Tuesday, March 8, 2022
Asthma, Compliance, Agency for Toxic Substances and Disease Registry, ANSI, Eureka, Poison, Multimedia, E-commerce, Nose, CARB, CDC, Agency, COPD, Formaldehyde, American National Standards Institute, NAF, 300X, View, Engineered wood, Online shopping

Traditional Brick and Mortar Stores have compliance teams that certify furniture to ensure compliance with federal standards whereas most online retailers do not.

Key Points: 
  • Traditional Brick and Mortar Stores have compliance teams that certify furniture to ensure compliance with federal standards whereas most online retailers do not.
  • Pressed-wood products should be labeled that they meet ultra-low emitting formaldehyde (ULEF) or no added formaldehyde (NAF) requirements.
  • Michael Whaley is the Vice President of Eureka Ergonomic, a major ecommerce furniture retailer.
  • He offers these words of warning to online consumers, "Some online sellers are not very concerned about the chemicals in products they offer.

BluePearl Pet Hospital Releases Annual Pet Health Trends Report, Revealing Most Pressing Health Issues Facing Pets Today

Retrieved on: 
Wednesday, February 23, 2022
Associate, Bird, Animal, Name, Coco, Millennials, Diagnosis, Toxicity, PETS, Awareness, Diarrhea, Reptile, Agency for Toxic Substances and Disease Registry, Overweight, Cat, Vomiting, Veterinarian, Life, Dog, BluePearl Veterinary Partners, Ecosystem, Hospital, Medical imaging, Pet

TAMPA, Fla., Feb. 23, 2022 /PRNewswire-PRWeb/ -- BluePearl Specialty and Emergency Pet Hospital today released its 2021 Pet Health Trends Report which reveals the year's most popular pet names and breeds, top pet diagnoses and toxicities, pet obesity and pet blood donations trends, and more.

Key Points: 
  • TAMPA, Fla., Feb. 23, 2022 /PRNewswire-PRWeb/ -- BluePearl Specialty and Emergency Pet Hospital today released its 2021 Pet Health Trends Report which reveals the year's most popular pet names and breeds, top pet diagnoses and toxicities, pet obesity and pet blood donations trends, and more.
  • "BluePearl's 2021 Pet Health Trends Report provides valuable pet health insights that can be leveraged by both pet owners and veterinary professionals," said Dr. James Barr, Chief Medical Officer at BluePearl.
  • BluePearl plans to release pet health trends reports annually to inform pet owners and the broader veterinary community of current and impending health issues for pets.
  • Laura Fourniotis, BluePearl Specialty and Emergency Pet Hospital, 813.327.6937, [email protected]
    Steve Ireland, BluePearl Specialty and Emergency Pet Hospital, 813.560.0029, [email protected]

Alfred W. Sandrock, Jr., M.D., Ph.D. Appointed to Voyager Therapeutics’ Board of Directors and Newly Formed Executive Committee

Retrieved on: 
Thursday, February 3, 2022
Voyager, Therapy, Disease, Neuromuscular disease, Biogen, Technology, Board of directors, Private Securities Litigation Reform Act, Research and development, GLOBE, Time, Communication, Drug, Biology, U.S. Securities and Exchange Commission, Executive Committee, Agency for Toxic Substances and Disease Registry, Robin, Brain, Intention, Convergent Technologies Operating System, S-1 Executive Committee, Harvard University, Company, Harvard Medical School, Research, RNA, Lists of diseases, Traffic barrier, Genzyme, Neuroscience, Product-service system, Neurology, Nasdaq, AAV, Cardiac muscle, Patient, Tissue, Tropism, Library, Board, Electromyography, Medicine, Massachusetts General Hospital, Hospital, Annual report, Stanford University, Quality, Medical device, Management, Pharmaceutical industry

CAMBRIDGE, Mass., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a gene therapy company developing life-changing treatments and next-generation adeno-associated virus (AAV) technologies, today announced the appointment of Alfred W. Sandrock, Jr., M.D., Ph.D. to its Board of Directors, effective February 7, and a newly formed Executive Committee of the Board consisting of Dr. Sandrock, Michael Higgins, interim chief executive officer and Board Chairman, and Glenn Pierce, M.D., Ph.D., interim chief scientific officer and Board member. Dr. Sandrock will work with Voyager leadership to help shape future strategies for the Company’s next-generation TRACERTM AAV capsid screening platform and therapeutic programs, and expand its external collaborations with scientific leaders and industry partners. The Company also announced the promotion of Robin Swartz to chief operating officer, effective February 7. As a component of this new role, Ms. Swartz will join the full leadership team in working closely with the Executive Committee, while overseeing Portfolio and Partner Management, IT, Finance, Communications, and Quality and Technology Operations.

Key Points: 
  • Al is a scientific visionary who led the development of multiple transformational therapies for serious neurological diseases.
  • Robin is a proven and respected leader whose passion for patients is reflected in her deep commitment to Voyager.
  • She also served on the Sanofi-Aventis US LLC board of directors and was a member of the Executive Leadership Team for three years.
  • Voyager Therapeutics (Nasdaq: VYGR) is leading the next generation of AAV gene therapy to unlock the potential of the technology to treat devastating diseases.

BluePearl Pet Hospital Launches Urgent Track Program to Address Growing Pet Care Demand and Provide Clear Urgent Care Career Path

Retrieved on: 
Tuesday, January 18, 2022
BluePearl Veterinary Partners, Patient, Associate, DVM, Veterinarian, Otology, Skin, Agency for Toxic Substances and Disease Registry, Knowledge, ER, Clinical professor, Degenerative disease, Health, PETS, Triage, Program, MS, Emergency medicine, Hospital, Medicine

TAMPA, Fla., Jan. 17, 2022 /PRNewswire-PRWeb/ -- BluePearl Specialty and Emergency Pet Hospital today announced the launch of a new clinician development program, Urgent Track .

Key Points: 
  • TAMPA, Fla., Jan. 17, 2022 /PRNewswire-PRWeb/ -- BluePearl Specialty and Emergency Pet Hospital today announced the launch of a new clinician development program, Urgent Track .
  • BluePearl's Urgent Track Program is uniquely designed for veterinarians looking to leverage and grow their clinical skill set with the option to career path into emergency medicine.
  • Urgent Track offers two career paths for veterinarians: urgent care and emergency medicine.
  • All BluePearl urgent care clinicians receive robust onboarding with virtual modules that cover subjects ranging from treatment of dermatologic urgencies to orthopedic exams to toxicities.